Computed tomography and F-18-FDG-positron emission tomography for staging lymphomas: a comparison

被引:15
作者
Bumann, D
de Wit, M
Beyer, W
Beese, M
Lubeck, M
Bucheler, E
Clausen, M
机构
[1] Univ Hamburg, Krankenhaus Eppendorf, Radiol Klin, Inst Rontgendiagnost, D-20246 Hamburg, Germany
[2] Univ Hamburg, Krankenhaus Eppendorf, Abt Onkol & Hamatol, D-20246 Hamburg, Germany
[3] Univ Hamburg, Krankenhaus Eppendorf, Inst Nukl Med, D-20246 Hamburg, Germany
来源
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN | 1998年 / 168卷 / 05期
关键词
malignant lymphoma; CT; PET; staging;
D O I
10.1055/s-2007-1015162
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose. To determine the value of F-18-FDG-positron emission tomography (FDG-PET) compared with computed tomography (CT) in the staging of malignant lymphomas. Material and method: 50 patients with biopsy-proven lymphoma were studied with FDG-PET and CT. The results in initial, posttherapeutic and staging of recurrence were compared. Results: 37 of 65 FDG-PET were identical with CT. 28 studies showed differences. 14 post-therapeutically and one of the initial studies led to downstaging by FDG-PET wereas upstaging resulted in one case of initial staging. In two cases false positive pulmonary FDG accumulations caused an upstaging. Conclusion: FDG-PET was at least comparable to CT in recording the extension of a newly diagnosed lymphoma or its recurrence. Upstaging according to FDG-PET occurred only once in initial staging. FDG-PET plays its most important role in the evaluation of residual mass in CT after therapy by accumulating FDG in viable tumour rather than in fibrotic tissue. 14 cases of downstaging according to FDG-PET resulted.
引用
收藏
页码:457 / 465
页数:9
相关论文
共 28 条
  • [1] CREMERIUS U, 1996, NUKL MED, V35, pA27
  • [2] DELONGO DL, 1993, CANCER, P1859
  • [3] Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma
    deWit, M
    Bumann, D
    Beyer, W
    Herbst, K
    Clausen, M
    Hossfeld, DK
    [J]. ANNALS OF ONCOLOGY, 1997, 8 : 57 - 60
  • [4] EVALUATION OF TUMOR METABOLISM AND MULTIDRUG-RESISTANCE IN PATIENTS WITH TREATED MALIGNANT-LYMPHOMAS
    DIMITRAKOPOULOUSTRAUSS, A
    STRAUSS, LG
    GOLDSCHMIDT, H
    LORENZ, WJ
    MAIERBORST, W
    VANKAICK, G
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1995, 22 (05): : 434 - 442
  • [5] DOHMEN BM, 1994, EUR J NUCL MED, V21, P727
  • [6] FLUORODEOXYGLUCOSE PET OF ABDOMINAL AND PELVIC NEOPLASMS - POTENTIAL ROLE IN ONCOLOGIC IMAGING
    GOLDBERG, MA
    LEE, MJ
    FISCHMAN, AJ
    MUELLER, PR
    ALPERT, NM
    THRALL, JH
    [J]. RADIOGRAPHICS, 1993, 13 (05) : 1047 - 1062
  • [7] COMPARISON OF INITIAL LYMPHOMA STAGING USING COMPUTED-TOMOGRAPHY (CT) AND MAGNETIC-RESONANCE (MR) IMAGING
    HOANE, BR
    SHIELDS, AF
    PORTER, BA
    BORROW, JW
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (02) : 100 - 105
  • [8] HOLLAND J, 1993, CANC MED
  • [9] HODGKIN DISEASE - CLINICAL UTILITY OF CT IN INITIAL STAGING AND TREATMENT
    HOPPER, KD
    DIEHL, LF
    LESAR, M
    BARNES, M
    GRANGER, E
    BAUMANN, J
    [J]. RADIOLOGY, 1988, 169 (01) : 17 - 22
  • [10] *ICRP, 1987, ICRP PUBL, V18, P142